The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Cadonilimab, a bispecific anti–PD-1/CTLA-4 antibody, for patients with dMMR/MSI-H metastatic colorectal cancer after progression on anti–PD-(L)1 therapy: A multicenter, single-arm, phase 2 trial (CSWOG-C03).
 
Huabin Hu
No Relationships to Disclose
 
Zhuoxin Zheng
No Relationships to Disclose
 
Jiaye Deng
No Relationships to Disclose
 
Lin Xie
No Relationships to Disclose
 
Jianwei Zhang
No Relationships to Disclose
 
Yan Zhang
No Relationships to Disclose
 
Xiaohui Zhai
No Relationships to Disclose
 
Xiaoyu Xie
No Relationships to Disclose
 
Zehua Wu
No Relationships to Disclose
 
Weiwei Li
No Relationships to Disclose
 
Wuteng Cao
No Relationships to Disclose
 
Fangqian Li
No Relationships to Disclose
 
Jiancong Hu
No Relationships to Disclose
 
Tao Yang
No Relationships to Disclose
 
Chao Wang
No Relationships to Disclose
 
Shan Zeng
No Relationships to Disclose
 
Lishuo Shi
No Relationships to Disclose
 
Yanhong Deng
No Relationships to Disclose